Kymera Therapeutics, Inc. - Common Stock (NQ:KYMR)

86.14 -2.86 (-3.21%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 16, 2026 Add to My Watchlist

Price and Volume

Volume	554,950
Open	88.93
Bid (Size)	82.50 (1,300)
Ask (Size)	88.04 (100)
Prev. Close	89.00
Today's Range	84.64 - 89.22
52wk Range	24.43 - 103.00
Shares Outstanding	55,307,775
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗

March 19, 2026

Kymera Therapeutics develops targeted protein degradation therapies for immunology and oncology, advancing a diversified clinical pipeline.

Via The Motley Fool

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗

March 09, 2026

This clinical-stage biotech targets retinal diseases with late-stage drug candidates and a focused pipeline in ophthalmology.

Via The Motley Fool

Performance

YTD	+18.4%	+18.4%
1 Month	+8.2%	+8.2%
3 Month	+14.5%	+14.5%
6 Month	+37.0%	+37.0%
1 Year	+238.3%	+238.3%

More News

Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗

March 06, 2026

Via The Motley Fool

Kymera Therapeutics Inc (NASDAQ:KYMR) Stock Falls 6.6% After Q4 2025 Earnings Miss and Extended Clinical Timelines ↗

February 26, 2026

Via Chartmill

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗

March 05, 2026

Via The Motley Fool

Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗

March 04, 2026

Via The Motley Fool

Kymera (KYMR) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position ↗

February 25, 2026

Via The Motley Fool

Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit ↗

February 25, 2026

Via The Motley Fool

Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction ↗

February 25, 2026

Via The Motley Fool

Kymera Stock Up 130% as $135 Million Buy Boosts Immunology Bet ↗

February 23, 2026

Via The Motley Fool

Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗

February 17, 2026

Via The Motley Fool

Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks ↗

January 01, 2026

Via MarketBeat

Streaming Wars Go Hostile Just as Wall Street Braces for the Fed ↗

December 09, 2025

Via Chartmill

What's going on in today's session ↗

December 08, 2025

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

December 08, 2025

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

December 08, 2025

Via Chartmill

Why Is KYMR Stock Up 30% Pre-Market Today? ↗

December 08, 2025

Via Stocktwits

These stocks are moving in today's after hours session ↗

December 05, 2025

Via Chartmill

Kymera (KYMR) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Via The Motley Fool

10 Analysts Have This To Say About Kymera Therapeutics ↗

November 05, 2025

Via Benzinga

Kymera Therapeutics Inc (NASDAQ:KYMR) Q3 2025 Earnings: Clinical Progress Overshadows Financial Miss ↗

November 04, 2025

Via Chartmill

The Analyst Verdict: Kymera Therapeutics In The Eyes Of 6 Experts ↗

October 17, 2025

Via Benzinga

Breaking Down Kymera Therapeutics: 4 Analysts Share Their Views ↗

September 16, 2025

Via Benzinga

Frequently Asked Questions

Is Kymera Therapeutics, Inc. - Common Stock publicly traded?

Yes, Kymera Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Kymera Therapeutics, Inc. - Common Stock trade on?

Kymera Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Kymera Therapeutics, Inc. - Common Stock?

The ticker symbol for Kymera Therapeutics, Inc. - Common Stock is KYMR on the Nasdaq Stock Market

What is the current price of Kymera Therapeutics, Inc. - Common Stock?

The current price of Kymera Therapeutics, Inc. - Common Stock is 86.14

When was Kymera Therapeutics, Inc. - Common Stock last traded?

The last trade of Kymera Therapeutics, Inc. - Common Stock was at 04/16/26 04:00 PM ET

What is the market capitalization of Kymera Therapeutics, Inc. - Common Stock?

The market capitalization of Kymera Therapeutics, Inc. - Common Stock is 4.76B

How many shares of Kymera Therapeutics, Inc. - Common Stock are outstanding?

Kymera Therapeutics, Inc. - Common Stock has 5B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.